IPC Partners
@ipcpartners.bsky.social
We are IPC Partners, a collaborative of experts providing infection prevention solutions to healthcare providers and corporate partners. We also run a regular IPC Journal Club. More info on our website: https://ipcpartners.org/
Reposted by IPC Partners
The Lowbury Reception kicks off to end a fantastic day 1 of #FIS25 - including a festive themed quiz hosted by BRITMIC. We look forward to welcoming everyone tomorrow for day 2!
December 2, 2025 at 6:06 PM
The Lowbury Reception kicks off to end a fantastic day 1 of #FIS25 - including a festive themed quiz hosted by BRITMIC. We look forward to welcoming everyone tomorrow for day 2!
Reposted by IPC Partners
Strengthening public health collaboration across Europe - Ricardo Mexia of Portugal’s National Health Institute shares why coordinated action matters for EU Health Task Force & Europe’s health security
Learn more about #EUHTF 👉 bit.ly/4pJWDN2
#HealthSecurity #Preparedness #ESCAIDE2025 #PublicHealth
Learn more about #EUHTF 👉 bit.ly/4pJWDN2
#HealthSecurity #Preparedness #ESCAIDE2025 #PublicHealth
#EUHTF in action — Ricardo Mexia — Strengthening Public Health Collaboration across Europe
YouTube video by ECDC
youtu.be
December 2, 2025 at 3:17 PM
Strengthening public health collaboration across Europe - Ricardo Mexia of Portugal’s National Health Institute shares why coordinated action matters for EU Health Task Force & Europe’s health security
Learn more about #EUHTF 👉 bit.ly/4pJWDN2
#HealthSecurity #Preparedness #ESCAIDE2025 #PublicHealth
Learn more about #EUHTF 👉 bit.ly/4pJWDN2
#HealthSecurity #Preparedness #ESCAIDE2025 #PublicHealth
Reposted by IPC Partners
💊 On Thursday, our Vice President Dr. Péter Álmos will speak during @ecdc.europa.eu's digital event 'From Resistance to Resilience: Healthcare Workers Leading the Change'
🗓️ 4 December 2025
🕐 13:00–15:00 CET
🔗 Register here: events.ringcentral.com/events/europ...
🗓️ 4 December 2025
🕐 13:00–15:00 CET
🔗 Register here: events.ringcentral.com/events/europ...
European Antibiotic Awareness Day 2025
Get tickets to European Antibiotic Awareness Day 2025, taking place 04/12/2025. RingCentral Events is your source for engaging events and experiences.
events.ringcentral.com
December 2, 2025 at 2:11 PM
💊 On Thursday, our Vice President Dr. Péter Álmos will speak during @ecdc.europa.eu's digital event 'From Resistance to Resilience: Healthcare Workers Leading the Change'
🗓️ 4 December 2025
🕐 13:00–15:00 CET
🔗 Register here: events.ringcentral.com/events/europ...
🗓️ 4 December 2025
🕐 13:00–15:00 CET
🔗 Register here: events.ringcentral.com/events/europ...
Reposted by IPC Partners
This study aims to evaluate the economic impact of a preventive intervention designed to reduce surgical site infection prevalence at the Fondazione Policlinico A. Gemelli.
https://www.journalofhospitalinfection.com/article/S0195-6701(25)00314-7/fulltext
https://www.journalofhospitalinfection.com/article/S0195-6701(25)00314-7/fulltext
December 2, 2025 at 2:55 PM
This study aims to evaluate the economic impact of a preventive intervention designed to reduce surgical site infection prevalence at the Fondazione Policlinico A. Gemelli.
https://www.journalofhospitalinfection.com/article/S0195-6701(25)00314-7/fulltext
https://www.journalofhospitalinfection.com/article/S0195-6701(25)00314-7/fulltext
Reposted by IPC Partners
📢 Get ready to take your outbreak management skills to next level in 2026!
Elevate your outbreak management skills at HIS HQ. You will gain:
1. Expert-Led Learning
2. Hands-On Experience
3. Real-World Applications
🚨Register now, limited spaces: https://ow.ly/NSsu50Xz5QA
#IPC
Elevate your outbreak management skills at HIS HQ. You will gain:
1. Expert-Led Learning
2. Hands-On Experience
3. Real-World Applications
🚨Register now, limited spaces: https://ow.ly/NSsu50Xz5QA
#IPC
December 2, 2025 at 1:05 PM
📢 Get ready to take your outbreak management skills to next level in 2026!
Elevate your outbreak management skills at HIS HQ. You will gain:
1. Expert-Led Learning
2. Hands-On Experience
3. Real-World Applications
🚨Register now, limited spaces: https://ow.ly/NSsu50Xz5QA
#IPC
Elevate your outbreak management skills at HIS HQ. You will gain:
1. Expert-Led Learning
2. Hands-On Experience
3. Real-World Applications
🚨Register now, limited spaces: https://ow.ly/NSsu50Xz5QA
#IPC
Reposted by IPC Partners
New Research
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
www.thelancet.com/journals/lan...
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
www.thelancet.com/journals/lan...
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
In people with advanced HIV disease, bictegravir, emtricitabine, and tenofovir alafenamide
was shown to be non-inferior to darunavir, cobicistat, emtricitabine, and tenofovir
alafenamide and resulted ...
www.thelancet.com
December 2, 2025 at 10:12 AM
New Research
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
www.thelancet.com/journals/lan...
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
www.thelancet.com/journals/lan...
Reposted by IPC Partners
Members of the British Infection Association can register for the members rate at the upcoming Dilemmas in Critical Care Infections Day on 20th January 2026 in Manchester
Register now👉 fitwise.eventsair.co...
#Infection #CriticalCareInfections #BIADilemmasDay2026
Register now👉 fitwise.eventsair.co...
#Infection #CriticalCareInfections #BIADilemmasDay2026
December 2, 2025 at 10:00 AM
Members of the British Infection Association can register for the members rate at the upcoming Dilemmas in Critical Care Infections Day on 20th January 2026 in Manchester
Register now👉 fitwise.eventsair.co...
#Infection #CriticalCareInfections #BIADilemmasDay2026
Register now👉 fitwise.eventsair.co...
#Infection #CriticalCareInfections #BIADilemmasDay2026
Reposted by IPC Partners
Autgors examined the risk factors for nosocomial Clostridioides difficile-induced diarrhea in hospitalized patients receiving enteral feeding and assess the impact of related factors on CDI outcomes
https://ow.ly/BZmL50XlXVJ
https://ow.ly/BZmL50XlXVJ
December 2, 2025 at 9:55 AM
Autgors examined the risk factors for nosocomial Clostridioides difficile-induced diarrhea in hospitalized patients receiving enteral feeding and assess the impact of related factors on CDI outcomes
https://ow.ly/BZmL50XlXVJ
https://ow.ly/BZmL50XlXVJ
Reposted by IPC Partners
#FIS25 officially kicks off this morning - we would like to welcome everyone to this year’s conference. Make sure to pop by our stand to find out more about the society’s activities, grab a copy of the JHI and a pack of Haribo 🍬
December 2, 2025 at 9:12 AM
#FIS25 officially kicks off this morning - we would like to welcome everyone to this year’s conference. Make sure to pop by our stand to find out more about the society’s activities, grab a copy of the JHI and a pack of Haribo 🍬
Reposted by IPC Partners
Reposted by IPC Partners
✅Get informed
✅Get screened
✅Get vaccinated
#CervicalCancer can be prevented & treated, if caught early. bit.ly/47GIbzd
#EndCervicalCancer
✅Get screened
✅Get vaccinated
#CervicalCancer can be prevented & treated, if caught early. bit.ly/47GIbzd
#EndCervicalCancer
December 2, 2025 at 7:03 AM
✅Get informed
✅Get screened
✅Get vaccinated
#CervicalCancer can be prevented & treated, if caught early. bit.ly/47GIbzd
#EndCervicalCancer
✅Get screened
✅Get vaccinated
#CervicalCancer can be prevented & treated, if caught early. bit.ly/47GIbzd
#EndCervicalCancer
Reposted by IPC Partners
We were delighted to welcome colleagues from Statens Serum Institut, Denmark's national disease prevention and control institute, to UKHSA last Thursday. 🇩🇰 🤝 🇬🇧
🌍 International partnerships like this are vital to our mission, and we look forward to building on this relationship with SSI.
🌍 International partnerships like this are vital to our mission, and we look forward to building on this relationship with SSI.
December 1, 2025 at 6:30 PM
We were delighted to welcome colleagues from Statens Serum Institut, Denmark's national disease prevention and control institute, to UKHSA last Thursday. 🇩🇰 🤝 🇬🇧
🌍 International partnerships like this are vital to our mission, and we look forward to building on this relationship with SSI.
🌍 International partnerships like this are vital to our mission, and we look forward to building on this relationship with SSI.
Reposted by IPC Partners
Authors conducted a comprehensive literature review focusing on studies exploring the risk-factors of short-term, non-hemodialysis central venous catheters published in the last two decades
https://ow.ly/fhqr50XmAUy
https://ow.ly/fhqr50XmAUy
December 1, 2025 at 5:45 PM
Authors conducted a comprehensive literature review focusing on studies exploring the risk-factors of short-term, non-hemodialysis central venous catheters published in the last two decades
https://ow.ly/fhqr50XmAUy
https://ow.ly/fhqr50XmAUy
Reposted by IPC Partners
🌍🎗 For World AIDS Day we highlight the importance of treatment in allowing people with HIV live long and healthy lives. More than half of people living with HIV are now over 50.
December 1, 2025 at 4:41 PM
🌍🎗 For World AIDS Day we highlight the importance of treatment in allowing people with HIV live long and healthy lives. More than half of people living with HIV are now over 50.
Reposted by IPC Partners
MRSA is widely used with different success rates and risk factors for failure reported. The authors aim to evaluate the success rate of MRSA decolonization and to identify risk factors for failure
https://ow.ly/NUc750XlXPm
https://ow.ly/NUc750XlXPm
December 1, 2025 at 3:50 PM
MRSA is widely used with different success rates and risk factors for failure reported. The authors aim to evaluate the success rate of MRSA decolonization and to identify risk factors for failure
https://ow.ly/NUc750XlXPm
https://ow.ly/NUc750XlXPm
Reposted by IPC Partners
#Obesity is a chronic, and complex disease requiring lifelong care.
People living with obesity, when medically advised, may use GLP-1 therapies.
The effect of these medications is enhanced when combined with physical activity, a healthy diet, and long-term follow ups.
People living with obesity, when medically advised, may use GLP-1 therapies.
The effect of these medications is enhanced when combined with physical activity, a healthy diet, and long-term follow ups.
December 1, 2025 at 2:46 PM
#Obesity is a chronic, and complex disease requiring lifelong care.
People living with obesity, when medically advised, may use GLP-1 therapies.
The effect of these medications is enhanced when combined with physical activity, a healthy diet, and long-term follow ups.
People living with obesity, when medically advised, may use GLP-1 therapies.
The effect of these medications is enhanced when combined with physical activity, a healthy diet, and long-term follow ups.
Reposted by IPC Partners
Want to talk about this matter with ECDC experts, public health professionals, NGO and patient organisations' representatives?
Join our online event at 3:30PM today!
Click to register: bit.ly/482o6U8
Join our online event at 3:30PM today!
Click to register: bit.ly/482o6U8
World AIDS Day: 2025 Digital Event
Get tickets to World AIDS Day: 2025 Digital Event, taking place 01/12/2025. RingCentral Events is your source for engaging events and experiences.
bit.ly
December 1, 2025 at 2:03 PM
Want to talk about this matter with ECDC experts, public health professionals, NGO and patient organisations' representatives?
Join our online event at 3:30PM today!
Click to register: bit.ly/482o6U8
Join our online event at 3:30PM today!
Click to register: bit.ly/482o6U8
Reposted by IPC Partners
We are seeking a talented Researcher in Evidence Synthesis to streamline clinical guideline development, rapid evidence review & knowledge mobilisation activities.
Apply ▶️https://ow.ly/o0zV50Xz0g1
#EvidenceSynthesis #GuidelineDevelopment #SystematicReview #Hiring
Apply ▶️https://ow.ly/o0zV50Xz0g1
#EvidenceSynthesis #GuidelineDevelopment #SystematicReview #Hiring
December 1, 2025 at 2:05 PM
We are seeking a talented Researcher in Evidence Synthesis to streamline clinical guideline development, rapid evidence review & knowledge mobilisation activities.
Apply ▶️https://ow.ly/o0zV50Xz0g1
#EvidenceSynthesis #GuidelineDevelopment #SystematicReview #Hiring
Apply ▶️https://ow.ly/o0zV50Xz0g1
#EvidenceSynthesis #GuidelineDevelopment #SystematicReview #Hiring
Reposted by IPC Partners
Today is #WorldAIDSDay.
Europe’s latest data show both progress and urgent gaps. #HIV diagnoses & #AIDS - related deaths continue to decline in the EU/EEA, but more than half of all HIV diagnoses are still made late.
bit.ly/WAD2025ECDC
#ECDC #ZeroStigma #EndStigma #WAD2025 #IDsky #EpiSky
Europe’s latest data show both progress and urgent gaps. #HIV diagnoses & #AIDS - related deaths continue to decline in the EU/EEA, but more than half of all HIV diagnoses are still made late.
bit.ly/WAD2025ECDC
#ECDC #ZeroStigma #EndStigma #WAD2025 #IDsky #EpiSky
December 1, 2025 at 2:03 PM
Today is #WorldAIDSDay.
Europe’s latest data show both progress and urgent gaps. #HIV diagnoses & #AIDS - related deaths continue to decline in the EU/EEA, but more than half of all HIV diagnoses are still made late.
bit.ly/WAD2025ECDC
#ECDC #ZeroStigma #EndStigma #WAD2025 #IDsky #EpiSky
Europe’s latest data show both progress and urgent gaps. #HIV diagnoses & #AIDS - related deaths continue to decline in the EU/EEA, but more than half of all HIV diagnoses are still made late.
bit.ly/WAD2025ECDC
#ECDC #ZeroStigma #EndStigma #WAD2025 #IDsky #EpiSky
Reposted by IPC Partners
Today is #WorldAIDSDay
With Lenacapavir or LEN, a new drug WHO recommends to protect people at risk of #HIV instead of taking daily pills, people can now get injections every 6 months.
At the time where funding for HIV is limited, this new drug could mean fewer new infections & more lives saved.
With Lenacapavir or LEN, a new drug WHO recommends to protect people at risk of #HIV instead of taking daily pills, people can now get injections every 6 months.
At the time where funding for HIV is limited, this new drug could mean fewer new infections & more lives saved.
December 1, 2025 at 9:32 AM
Today is #WorldAIDSDay
With Lenacapavir or LEN, a new drug WHO recommends to protect people at risk of #HIV instead of taking daily pills, people can now get injections every 6 months.
At the time where funding for HIV is limited, this new drug could mean fewer new infections & more lives saved.
With Lenacapavir or LEN, a new drug WHO recommends to protect people at risk of #HIV instead of taking daily pills, people can now get injections every 6 months.
At the time where funding for HIV is limited, this new drug could mean fewer new infections & more lives saved.
Reposted by IPC Partners
🚨 1 week to go! Contamination outbreaks from healthcare products put patients at risk. Join our HIS x UK Health Security Agency webinar on 8 Dec, 13:00 GMT for lessons, risks & IPC tips.
🔗 Register: https://ow.ly/4tSo50XuEhi
🔗 Send questions by 2 Dec: https://ow.ly/RFtf50XuEkA
#IPC #AMR
🔗 Register: https://ow.ly/4tSo50XuEhi
🔗 Send questions by 2 Dec: https://ow.ly/RFtf50XuEkA
#IPC #AMR
December 1, 2025 at 9:05 AM
🚨 1 week to go! Contamination outbreaks from healthcare products put patients at risk. Join our HIS x UK Health Security Agency webinar on 8 Dec, 13:00 GMT for lessons, risks & IPC tips.
🔗 Register: https://ow.ly/4tSo50XuEhi
🔗 Send questions by 2 Dec: https://ow.ly/RFtf50XuEkA
#IPC #AMR
🔗 Register: https://ow.ly/4tSo50XuEhi
🔗 Send questions by 2 Dec: https://ow.ly/RFtf50XuEkA
#IPC #AMR
Reposted by IPC Partners
Tracing Klebsiella pneumoniae in intensive care units using genomic methods and a new rapid Sequence Type assignment technique: Three years of molecular epidemiology results
https://ow.ly/HAUI50XlXSv
https://ow.ly/HAUI50XlXSv
December 1, 2025 at 8:55 AM
Tracing Klebsiella pneumoniae in intensive care units using genomic methods and a new rapid Sequence Type assignment technique: Three years of molecular epidemiology results
https://ow.ly/HAUI50XlXSv
https://ow.ly/HAUI50XlXSv
Reposted by IPC Partners
Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam against Metallo-ß-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-Based Model
✅ Just Accepted
🔗 https://bit.ly/3WUrcmU
✅ Just Accepted
🔗 https://bit.ly/3WUrcmU
December 1, 2025 at 3:10 AM
Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam against Metallo-ß-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-Based Model
✅ Just Accepted
🔗 https://bit.ly/3WUrcmU
✅ Just Accepted
🔗 https://bit.ly/3WUrcmU
Reposted by IPC Partners
Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial.
https://bit.ly/488AFNv
https://bit.ly/488AFNv
Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial
Post-exposure doxycycline-based prophylaxis was associated with a significant increase in the frequency of N. gonorrhoeae isolates with high-level resistan
bit.ly
November 30, 2025 at 9:49 PM
Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial.
https://bit.ly/488AFNv
https://bit.ly/488AFNv
Reposted by IPC Partners
CRISPR-Cas?associated SCCmec variants in methicillin-resistant Staphylococcus aureus evade rapid diagnostic detection
✅ Just Accepted
🔗 https://bit.ly/3LWRti0
✅ Just Accepted
🔗 https://bit.ly/3LWRti0
November 30, 2025 at 8:35 PM
CRISPR-Cas?associated SCCmec variants in methicillin-resistant Staphylococcus aureus evade rapid diagnostic detection
✅ Just Accepted
🔗 https://bit.ly/3LWRti0
✅ Just Accepted
🔗 https://bit.ly/3LWRti0